U.S. Markets closed

Envision Healthcare Corporation (EVHC)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
44.37+1.26 (+2.92%)
At close: 4:03PM EDT

44.37 0.00 (0.00%)
After hours: 4:42PM EDT

People also watch
TMHMDACHCCYHUHS
Full screen
Previous Close43.11
Open43.12
Bid35.00 x 100
Ask50.00 x 200
Day's Range43.10 - 45.10
52 Week Range43.10 - 74.75
Volume3,756,238
Avg. Volume1,816,095
Market Cap5.29B
Beta0.21
PE Ratio (TTM)-8.07
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Barrons.com7 hours ago

    Do We Need To Worry About Healthcare Reform Yet Again?

    Healthcare names sold off yesterday, on investor fears that Republican senators were gaining some ground in one more attempt to repeal the Affordable Care Act. Jefferies' Brian Tanquilut and his team write that while it's difficult to say at the moment what the likelihood of this latest bill passing actually is, a number of the stocks that fell yesterday shouldn't have. Tanquilut writes that "last-gasp" efforts to repeal the ACA have seemingly picked up steam in the past few days, but he still thinks that the new bill is a long shot given the lack of support, a tight deadline, and a lack of a score from the CBO.

  • Envision Healthcare Makes Organizational Changes, Here's Why
    Zacks7 hours ago

    Envision Healthcare Makes Organizational Changes, Here's Why

    Envision Healthcare (EVHC) rejigs top management and announces share buyback as it realigns business.

  • Barrons.comyesterday

    The Biggest Loser: Envision Healthcare Slumps 9.6%

    Envision Healthcare (EVHC) tumbled to the bottom of the S&P 500 today after announcing the retirement of its CFO and the departure of its Physician Services segment President. The Health Care Select Sector SPDR ETF (XLV) fell 0.8% to $81.92. Jefferies analyst Brian Tanquilut focuses on the departure of President of Physician Services Bob Coward: Outgoing President of Physician Services Bob Coward was highly regarded, both by investors and other healthcare services operators, so his departure is slightly disappointing to us.